Madrigal Pharmaceuticals Inc (MDGL)

04:44 AM

Madrigal Pharmaceuticals announces grants of inducement awards under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

04:44 AM

04:05 AM

Madrigal Pharmaceuticals (NASDAQ: MDGL) grants 2,125 RSUs to hires under inducement plan - Stock Titan

04:05 AM

11:32 AM

Jefferies 25: The Cardiometabolic Revolution Is Going Global - Citeline News & Insights

11:32 AM

08:34 AM

Oppenheimer Adjusts Price Target on Madrigal Pharmaceuticals to $650 From $600, Maintains Outperform Rating - MarketScreener

08:34 AM

06:43 AM

What margin trends mean for Madrigal Pharmaceuticals Inc. stockChart Signals & Momentum Based Trading Ideas - newser.com

06:43 AM

06:38 AM

Madrigal Pharmaceuticals (MDGL): Oppenheimer Raises Price Target - GuruFocus

06:38 AM

06:28 AM

Oppenheimer raises Madrigal Pharmaceuticals stock price target on positive Rezdiffra data - Investing.com Canada

06:28 AM

01:03 AM

Will Madrigal Pharmaceuticals Inc. stock pay special dividendsJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com

01:03 AM

Nov 19, 2025

Is Madrigal Pharmaceuticals Inc. (YDO1) stock in buy zone after pullbackPortfolio Return Report & Low Volatility Stock Suggestions - newser.com

Nov 19, 2025

Nov 19, 2025

How Madrigal Pharmaceuticals Inc. (YDO1) stock reacts to Fed tighteningJuly 2025 PreEarnings & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Why Madrigal Pharmaceuticals Inc. (YDO1) stock is listed among top recommendationsTrade Ideas & Real-Time Price Movement Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Madrigal Pharmaceuticals stock price target raised by Truist on MASH potential - Investing.com South Africa

Nov 19, 2025

Nov 19, 2025

Can Madrigal Pharmaceuticals Inc. stock sustain market leadershipTrade Entry Report & Safe Entry Trade Signal Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Madrigal Pharmaceuticals (MDGL) Rating Maintained and Price Target Raised by Truist Securities | MDGL Stock News - GuruFocus

Nov 19, 2025

Nov 19, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep raising dividendsJuly 2025 Selloffs & Safe Entry Point Identification - newser.com

Nov 19, 2025

Nov 19, 2025

Why analysts recommend Madrigal Pharmaceuticals Inc. (YDO1) stockWall Street Watch & Accurate Entry/Exit Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Truist Raises Price Target on Madrigal Pharmaceuticals to $640 From $580, Keeps Buy Rating - MarketScreener

Nov 19, 2025

Nov 19, 2025

How Madrigal Pharmaceuticals Inc. (YDO1) stock performs in volatility spikes2025 Short Interest & Long-Term Safe Investment Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock extend growth storyWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com

Nov 19, 2025

Nov 19, 2025

From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews

Nov 19, 2025

Nov 19, 2025

Visual analytics tools that track Madrigal Pharmaceuticals Inc. performanceMarket Growth Report & Fast Gain Stock Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Is it too late to sell Madrigal Pharmaceuticals Inc.July 2025 Sector Moves & Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones - Yahoo Finance

Nov 19, 2025

Nov 19, 2025

Madrigal Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Review & Risk Controlled Stock Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Madrigal Pharmaceuticals (MDGL) Is Up 5.7% After Positive Phase 3 Rezdiffra Results in Advanced MASH Cirrhosis - Yahoo Finance

Nov 18, 2025

Nov 18, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock sustain dividend payoutsWall Street Watch & Low Risk High Reward Ideas - newser.com

Nov 18, 2025

Nov 18, 2025

Do You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)? - Yahoo Finance

Nov 18, 2025

Nov 18, 2025

Breakthrough Liver Drug Shows Powerful Two-Year Gains — But Raises a Critical Warning - MyChesCo

Nov 18, 2025

Nov 17, 2025

Madrigal Pharmaceuticals stock hits all-time high at 545.0 USD By Investing.com - Investing.com UK

Nov 17, 2025

Nov 17, 2025

Madrigal Pharma (NASDAQ: MDGL) sets fireside chats at three investor conferences - Stock Titan

Nov 17, 2025

Nov 17, 2025

How to escape a deep drawdown in Madrigal Pharmaceuticals Inc.2025 Top Gainers & Community Verified Swing Trade Signals - newser.com

Nov 17, 2025

Nov 17, 2025

Madrigal Pharmaceuticals (BIT:1MDGL) Price Target Increased by 11.64% to 485.78 - Nasdaq

Nov 17, 2025